Showing all 4 results
Diphenylhydantoin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Dissolution-Optimized Macrodose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the highly reactive sodium salt.
Active Ingredient Strength Primary Clinical Function Diphenylhydantoin (Phenytoin) Sodium USP/Ph.Eur. 100 mg The Global Epilepsy Standard: The definitive therapeutic unit utilized globally for the chronic, daily maintenance and suppression of tonic-clonic and psychomotor seizures. Excipients Microcrystalline Cellulose / Lactose Monohydrate / Sodium Starch Glycolate / Povidone / Magnesium Stearate Diluent / Binder / Superdisintegrant / Glidant / Lubricant (Engineered specifically utilizing Strict Particle-Size Distribution (PSD) Control. Because the drug is highly insoluble, the API is micro-milled to an exact, mathematically defined micron size to guarantee a highly predictable, extended dissolution profile in the gut, preventing toxic “dose dumping”) *Pack Sizes: Bottles of 100 or 10×10 Blisters (Optimized specifically for strict chronic neurology dispensing regimens and therapeutic drug monitoring protocols).
Ergotamine & Caffeine ,Paracetamol and Prochlorperazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Quad-API Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the sensitive ergot alkaloid and phenothiazine components.
Active Ingredient Strength Primary Clinical Function Ergotamine Tartrate USP/Ph.Eur. 1 mg The Vascular Terminator (Micro-Dose): The foundational ergot alkaloid required to aggressively constrict pulsing cranial arteries. Caffeine Anhydrous USP/Ph.Eur. 100 mg The Absorption Catalyst: Enhances Ergotamine bioavailability and accelerates onset of action. Paracetamol (Acetaminophen) USP/Ph.Eur. 250 mg The Central Analgesic (Macro-Dose): Provides immediate, broad-spectrum relief from accompanying head and neck pain. Prochlorperazine Maleate USP/Ph.Eur. 2.5 mg The Antiemetic Anchor (Ultra-Micro-Dose): Lethally blocks the CTZ to prevent vomiting and ensure full gastrointestinal absorption of the FDC. Excipients Microcrystalline Cellulose / Croscarmellose Sodium / Povidone K-30 / Magnesium Stearate / Premium Polymeric Film Diluent / Superdisintegrant / Binder / Lubricant (Engineered utilizing extreme multi-stage geometric dilution to flawlessly blend a microscopic 1mg and 2.5mg payload into a massive 250mg/100mg base, guaranteeing absolute content uniformity and zero toxic ‘hot spots’) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for strict, heavily limited acute neurology dispensing to prevent ergot toxicity).
Flunarazine Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, High-Density Microdose Tablet, packed exclusively in highly secure, moisture-resistant Alu-PVC or Alu-Alu blister strips to ensure the absolute chemical stability of the dihydrochloride salt.
Active Ingredient Strength Primary Clinical Function Flunarizine (as Dihydrochloride) USP/Ph.Eur. 5 mg The Pediatric & Geriatric Standard: The definitive low-dose unit required for migraine prophylaxis in children or for treating vertigo in elderly patients who are highly sensitive to drug accumulation. Flunarizine (as Dihydrochloride) USP/Ph.Eur. 10 mg The Global Adult Migraine Standard: High-efficacy adult maintenance dose utilized for maximum suppression of chronic, refractory migraine attacks. Excipients Lactose Monohydrate / Microcrystalline Cellulose / Crospovidone / Colloidal Silicon Dioxide / Magnesium Stearate Diluent / Binder / Superdisintegrant / Glidant / Lubricant (Engineered utilizing elite low-dose geometric dilution to guarantee that the 5mg or 10mg micro-dose is flawlessly distributed, preventing accidental drug-accumulation spikes) *Pack Sizes: 10×10 Blisters (Optimized specifically for strict, heavily monitored 3-to-6 month neurology dispensing regimens).
